These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1512 related items for PubMed ID: 9222546

  • 1. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M, García-Sevilla JA.
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [Abstract] [Full Text] [Related]

  • 2. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
    Alemany R, Olmos G, García-Sevilla JA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
    [Abstract] [Full Text] [Related]

  • 3. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A, Esteban S, Sastre-Coll A, Moranta D, Asensio VJ, García-Sevilla JA.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):234-42. PubMed ID: 16061219
    [Abstract] [Full Text] [Related]

  • 4. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A, Olmos G, Sastre M, Barturen F, Martin I, Garcia-Sevilla JA.
    J Pharmacol Exp Ther; 1993 Mar 22; 264(3):1187-97. PubMed ID: 8095548
    [Abstract] [Full Text] [Related]

  • 5. Characterisation of imidazoline I2 binding sites in pig brain.
    Anderson NJ, Lupo PA, Nutt DJ, Hudson AL, Robinson ES.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):68-74. PubMed ID: 16109401
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
    Carpéné C, Collon P, Remaury A, Cordi A, Hudson A, Nutt D, Lafontan M.
    J Pharmacol Exp Ther; 1995 Feb 05; 272(2):681-8. PubMed ID: 7853182
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA, Olmos G, García-Sevilla JA.
    Br J Pharmacol; 1998 Sep 05; 125(1):175-85. PubMed ID: 9776358
    [Abstract] [Full Text] [Related]

  • 8. Modulation of MAO activity by imidazoline and guanidine derivatives.
    Raasch W, Muhle H, Dominiak P.
    Ann N Y Acad Sci; 1999 Jun 21; 881():313-31. PubMed ID: 10415932
    [Abstract] [Full Text] [Related]

  • 9. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R, Olmos G, García-Sevilla JA.
    Br J Pharmacol; 1995 Feb 21; 114(4):837-45. PubMed ID: 7773544
    [Abstract] [Full Text] [Related]

  • 10. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
    King PR, Suzuki S, Hosseini AR, Iakovidis D, Nero TL, Jackman GP, Louis WJ, Gundlach AL.
    J Auton Nerv Syst; 1998 Oct 15; 72(2-3):118-28. PubMed ID: 9851560
    [Abstract] [Full Text] [Related]

  • 11. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit.
    Lanier B, Raddatz R, Bakthavachalam V, Coupry I, Neumeyer JL, Lanier SM.
    Mol Pharmacol; 1995 Oct 15; 48(4):703-10. PubMed ID: 7476897
    [Abstract] [Full Text] [Related]

  • 12. Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme.
    Raddatz R, Savic SL, Bakthavachalam V, Lesnick J, Jasper JR, McGrath CR, Parini A, Lanier SM.
    J Pharmacol Exp Ther; 2000 Mar 15; 292(3):1135-45. PubMed ID: 10688633
    [Abstract] [Full Text] [Related]

  • 13. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A, Widdowson PS, Cordi A.
    Br J Pharmacol; 1993 Jul 15; 109(3):625-31. PubMed ID: 8102932
    [Abstract] [Full Text] [Related]

  • 14. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine.
    Wiest SA, Steinberg MI.
    Life Sci; 1997 Jul 15; 60(9):605-15. PubMed ID: 9048963
    [Abstract] [Full Text] [Related]

  • 15. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
    Limon-Boulez I, Tesson F, Gargalidis-Moudanos C, Parini A.
    J Pharmacol Exp Ther; 1996 Feb 15; 276(2):359-64. PubMed ID: 8632297
    [Abstract] [Full Text] [Related]

  • 16. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
    Bour S, Iglesias-Osma MC, Marti L, Duro P, Garcia-Barrado MJ, Pastor MF, Prévot D, Visentin V, Valet P, Moratinos J, Carpéné C.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):20-30. PubMed ID: 17056035
    [Abstract] [Full Text] [Related]

  • 17. Nonadrenergic imidazoline binding sites on human platelets.
    Piletz JE, Sletten K.
    J Pharmacol Exp Ther; 1993 Dec 15; 267(3):1493-502. PubMed ID: 8263811
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.
    Hosseini AR, Jackman GP, King PR, Louis WJ, Gundlach AL.
    J Auton Nerv Syst; 1998 Oct 15; 72(2-3):129-36. PubMed ID: 9851561
    [Abstract] [Full Text] [Related]

  • 19. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
    King PR, Gundlach AL, Louis WJ.
    Ann N Y Acad Sci; 1999 Jun 21; 881():161-70. PubMed ID: 10415911
    [Abstract] [Full Text] [Related]

  • 20. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
    Hosseini AR, King PR, Louis WJ, Gundlach AL.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan 21; 355(1):131-8. PubMed ID: 9007853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.